Choosing an insulin pump is one of the bigger decisions in Type 1 diabetes management — and one of the areas where we find our patients most underserved by the information available to them. Every manufacturer's website naturally makes their own system look like the obvious choice. Device reps are enthusiastic advocates for a single platform. And online communities, while invaluable, are populated by people who love the system they already picked.
We have started patients on all three major systems. We do not have a house favorite — we have favorites for specific patients. This article is our attempt to give you an honest, comparative picture before that conversation happens at your visit.
What an insulin pump actually is
An insulin pump is a small wearable device that delivers insulin continuously throughout the day. Instead of multiple daily injections, the pump provides a steady low-level dose of rapid-acting insulin (your basal rate) and lets you dial in additional doses for meals (boluses) on demand. The pump holds a reservoir of rapid-acting insulin — no long-acting insulin is used when you are pumping.
Modern closed-loop systems go one step further: they read glucose data from a continuous glucose monitor (CGM) in real time and automatically adjust the basal rate up or down based on where your glucose is and where it is trending. These are called hybrid closed-loop systems because the pump handles basal automatically, but you still announce meals by entering a carb count to trigger a meal bolus. The system is "closed" for basal; you remain in the loop for meals.
The result is meaningful: more time in range, fewer overnight lows, and substantially less mental math than traditional pump therapy or multiple daily injections.
The three major systems we work with
Tandem t:slim X2 + Control-IQ
The t:slim X2 is a tubed pump — a small device you wear on your body, connected to an infusion set (a thin soft cannula inserted under the skin) by a short length of tubing. The reservoir holds up to 300 units and is filled using a cartridge system. The pump has a color touchscreen and a rechargeable battery charged via USB, like a phone.
The t:slim X2 pairs with Dexcom G6 or G7 CGM. The algorithm driving automated insulin delivery is called Control-IQ, and it is one of the most clinically studied closed-loop algorithms available. Control-IQ makes basal adjustments every five minutes based on the CGM reading and a prediction of where glucose is heading. It also delivers automatic correction boluses when it predicts glucose will remain above target.
A feature that distinguishes Tandem from any competitor: you can update the pump software via USB without replacing the device. When Tandem releases algorithm improvements, existing pumps receive them as a software update — called Tandem Source. This means the pump you buy today can improve over time without a hardware change.
Control-IQ also has two activity-based modes you manually activate: Sleep Activity, which tightens the glucose target overnight, and Exercise Activity, which loosens the target to reduce hypoglycemia risk during workouts.
Omnipod 5
The Omnipod 5 is tubeless. The entire pump — insulin reservoir, motor, and infusion cannula — is contained in a small pod that adheres directly to your skin. There is no tubing at all. Pods are disposable and worn for up to three days, then peeled off and replaced with a fresh one.
The Omnipod 5 pairs with Dexcom G6 or G7. You control it either from a dedicated personal diabetes manager (PDM) or directly from a compatible smartphone (iOS and Android both supported). There is no wire between you and your insulin delivery — the pod communicates wirelessly with the controller.
For many patients, the absence of tubing is not a minor convenience — it is the deciding factor. Swimming, contact sports, body image, getting dressed, and sleeping all look different without a tube. Pods can be worn on the back of the upper arm, the abdomen, thigh, or lower back. Because each pod is fully self-contained, you can move to a new site without any priming or reconfiguration.
The Omnipod 5 algorithm is effective at managing glucose, though in head-to-head comparisons and clinical experience, its aggressiveness in correcting highs is somewhat less assertive than Control-IQ. Pod failures — where a pod occludes, errors out, or detaches prematurely — occur in roughly 2–5% of pod applications in real-world data. This is manageable, but it is worth knowing and planning for.
Medtronic MiniMed 780G + Guardian 4
The 780G is a tubed pump, similar in form factor to the t:slim X2. It is Medtronic's current flagship, and its algorithm distinguishes itself in one important way: the 780G delivers automatic correction boluses in Auto Mode, not just basal adjustments. When glucose is above target, the pump actively corrects it by delivering a calculated micro-bolus without requiring you to initiate anything. This level of automation is meaningful, particularly for patients who tend to under-bolus or who are not consistent carb counters.
The 780G uses Medtronic's own CGM ecosystem — the Guardian 4 sensor or the newer Simplera. This is both a strength and a limitation. Patients who have been using Dexcom for years and trust its accuracy often find the transition to a Medtronic CGM a significant adjustment. Guardian sensors are not interchangeable with Dexcom. If you are committed to Dexcom, the 780G is not compatible.
The 780G's algorithm is aggressive and performs well in clinical trials, with very strong time-in-range data, particularly for patients who use the automatic correction feature. For patients who struggle with carb counting, forget meal boluses, or have highly variable eating patterns, the auto-correction capability can be genuinely valuable in ways that other systems require more patient engagement to match.
Closed-loop / hybrid closed-loop explained
All three systems operate in what is called hybrid closed-loop mode. Here is how to think about it:
The pump reads your CGM value every five minutes. If glucose is rising toward the upper threshold, it increases your basal rate. If glucose is dropping, it reduces or suspends insulin delivery. This happens automatically in the background, 24 hours a day.
What you still do: announce meals. When you eat, you tell the pump how many carbohydrates you are consuming, and the pump calculates and delivers a meal bolus. The systems can learn your typical correction factor and carb ratio over time and refine their estimates, but the meal announcement step is yours.
"Auto Mode" is the term most systems use for the active closed-loop state. Being in Auto Mode means the algorithm is actively adjusting insulin based on CGM data. Being out of Auto Mode — which happens if CGM data is unavailable, if glucose is severely out of range, or if you manually suspend — means you are back to traditional manual pump therapy.
What closed-loop systems consistently deliver in practice: reduced overnight hypoglycemia, improved time in range, fewer extreme highs and lows, and substantially lower mental load for many patients. Many of our patients sleep through the night with stable glucose for the first time in years after starting a closed-loop system.
Honest tradeoffs by system
The differences that actually matter in day-to-day use are worth naming directly.
Tandem t:slim X2: excellent algorithm with meaningful auto-correction, touchscreen that patients find intuitive, Dexcom G7 integration (currently the most accurate widely used CGM), software updates without device replacement, and well-studied clinical outcomes. The main limitation is the tubing — some patients adapt easily; others find it an ongoing frustration. The cartridge fill process takes a few more minutes than pod replacement.
Omnipod 5: no tubing is a genuine quality-of-life win for a significant portion of patients. Swimming and water immersion are no issue. Sports, kids, body image — these conversations are different without a tube. Phone control via iOS or Android is convenient. The main tradeoffs: the adhesive cycle every three days is constant, pod failures happen and require a full pod change (not just an infusion set swap), and the algorithm is slightly less aggressive at bringing down elevated glucose than Control-IQ.
Medtronic 780G: auto-correction boluses are a real differentiator — no other major system currently delivers bolus-level corrections automatically in closed-loop mode. For patients who are not reliable carb counters or who tend to miss correction doses, this matters. The limitation most relevant to our patient population: the Medtronic CGM requirement. Patients who have established trust and comfort with Dexcom — which represents the majority of our experienced CGM users — often find the switch difficult.
What is coming in 2026–2027
A few systems worth being aware of as you plan for a device you will likely wear for several years:
Beta Bionics iLet is a bionic pancreas that functions without carb counting — you declare a meal as small, medium, or large, and the algorithm handles the rest. It has FDA clearance and is in limited launch as of 2026. If carb counting is your biggest barrier to good control, this is a system to watch.
Sequel Med Tech (Twiist) is a newer tubed pump entrant with a different control architecture. It is still establishing its clinical footprint.
Tandem Mobi is a smaller form-factor tubed pump from Tandem — more discreet than the t:slim X2, designed for patients who want the Control-IQ algorithm in a smaller package.
The landscape is moving. When we have a device conversation with you, we will tell you where each system currently stands and whether a product you are interested in is worth waiting for given your timeline.
How to think about choosing
Rather than a ranking, we find it more useful to think about the patient in front of us.
- Activity level and lifestyle. If you play contact sports, swim competitively, or are a kid who does not want to manage tubing, Omnipod is almost always the right answer. If you exercise heavily but can manage brief disconnection during activity, Tandem is workable.
- CGM preference. If you have years of Dexcom experience and trust it, Tandem or Omnipod both pair with G7 — stay in that ecosystem. If you are new to CGM and open to either platform, consider the full pump picture first.
- Tubing tolerance. If the idea of a tube is a hard no, Omnipod is the only option. There is no hybrid — Omnipod is truly tubeless.
- Phone control preference. If you want to control your pump from an iPhone or Android, Omnipod 5 offers the most flexible phone control. Tandem's mobile bolus support is available via app but has some platform limitations.
- Carb counting comfort. If you are confident and consistent at counting carbohydrates, any system works well. If carb counting is a persistent challenge or you frequently miss meal boluses, the 780G's auto-correction architecture is worth serious consideration.
- Insurance. Coverage for each system varies by plan and year. All three are covered by most commercial plans with prior authorization. Our team runs the prior auth — you do not navigate that alone.
- Eversense + pump? Eversense 365 is an excellent implantable CGM that we place in-office. However, Eversense is not currently integrated with any closed-loop pump algorithm — it is CGM-only for now. If closed-loop pump therapy is your goal, you will use Dexcom or the Medtronic CGM, not Eversense.
What the pump start process looks like at EPC
We do pump starts in-office. This is a full-day commitment — not a 90-minute orientation followed by a handout.
Pre-pump education is typically one or two visits with our Certified Diabetes Care and Education Specialist (CDCES) before your pump arrives. These visits cover how pumps work, carb counting for pump therapy, what to do when a site fails, sick-day rules, and how to prevent DKA during pump therapy. You arrive on pump training day already having thought through the basics.
Pump training day is a four-to-six-hour in-office session. We unbox your pump together, load your insulin, place your first infusion set or pod, and configure your initial settings. We walk through every screen and every situation we can anticipate. You leave that day wearing a functioning pump with settings calibrated to your history, not generic defaults.
The first two weeks involve frequent check-ins every three to five days. This is when we catch the patterns that need early adjustment: the morning basal that needs to come up, the post-lunch pattern the algorithm has not yet learned, the site rotation question you forgot to ask on training day.
The first month is intensive CGM review. We look at your ambulatory glucose profile together at each visit, focus on time in range, and tune settings based on real-world data rather than estimates.
Long-term, once you are stable and comfortable, most pump patients are seen every three months. Ongoing optimization continues throughout — pumps are not set-it-and-forget-it devices.
Common pump start concerns
- "Will I have to wear it all the time?" Yes — with limited exceptions. Most pumps tolerate brief disconnection of 30 to 60 minutes for showers, swimming, or specific activities. Extended disconnection requires a plan and often a correction afterward.
- "What if it fails?" We have a fallback plan ready before you ever put on the pump. You will know your multiple daily injection regimen — the insulin types, doses, and timing to use if your pump is unavailable. Most pump failures involve a site issue or pod error, not the pump hardware itself.
- "Can I switch later if I don't like it?" Yes. Most insurance covers a system switch after one to two years. We have helped patients switch systems when their lifestyle changed, and we will help you navigate that if it comes to it.
- "Do pumps replace fingersticks?" For patients with an integrated CGM, mostly yes. We still recommend a fingerstick when your CGM reading and your symptoms disagree, or during rapid glucose changes where CGM lag matters.
- "What about overnight?" This is where closed-loop systems genuinely shine. Many of our patients describe the first stable overnight after starting a closed-loop system as one of the most meaningful changes in years of diabetes management. The algorithm works while you sleep, catching drops before they become lows, and preventing the 3 AM hypoglycemia that used to require an alarm and a juice box.
Our honest take from practice
We do not have a favorite pump. We have a favorite pump for each patient in front of us.
The patient who plays rugby three days a week and hates anything attached to a tube — that patient gets Omnipod. The teenager who wants the most aggressive algorithm and is comfortable with some tubing — often Tandem. The adult who has been on insulin for thirty years, does not carb count consistently, and needs the auto-correction to fill in the gaps — sometimes the 780G is the right answer.
What matters more than any specification sheet: your lifestyle, your CGM history, your willingness to engage with technology, and the particular challenges you have faced with glucose management until now. Vendors optimize their marketing. We try to optimize the match.
We have successfully started patients on all three platforms and follow patients on all three long-term. When you are ready for this conversation, we are ready to have it — without a sales pitch.
Let us help you decide
If you are exploring pump therapy for the first time, or if you are already on a pump and wondering whether a different system would serve you better, schedule a visit at either our Houston or Katy location. We will review your CGM data, your glucose history, your lifestyle, and your insurance coverage — and give you our honest recommendation.
Pump therapy is one of the most impactful tools we have for Type 1 diabetes. Getting the right system matters. We are glad to help you find it.